35 assets in Anaplastic Astrocytoma

Therapeutic assets addressing Anaplastic Astrocytoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cediranib Anaplastic Astrocytoma	National Cancer Institute (NCI)	P2	BBB (73)
Irinotecan Anaplastic Astrocytoma	City of Hope Medical Center	P2/3	BBB (73)
(+)-Vincristine Anaplastic Astrocytoma	Novartis Pharmaceuticals	P2/3	BB (70)
Carboplatin Anaplastic Astrocytoma	Oliver Jonas	P2	BB (67)
Trametinib Anaplastic Astrocytoma	National Cancer Institute (NCI)	P4	BB (65)
Cetuximab Anaplastic Astrocytoma	University of Miami	P2	B (62)
Dabrafenib Anaplastic Astrocytoma	National Cancer Institute (NCI)	P4	B (62)
Veliparib Anaplastic Astrocytoma	National Cancer Institute (NCI)	P2	B (61)
Everolimus Anaplastic Astrocytoma	Nationwide Children's Hospital	P2	B (58)
Ribociclib Anaplastic Astrocytoma	Nationwide Children's Hospital	P2	B (58)
Mannitol Anaplastic Astrocytoma	Northwell Health	P2	B (57)
db107-fc Anaplastic Astrocytoma	Ashish Shah	P2	CCC (53)
db107-rrv Anaplastic Astrocytoma	Ashish Shah	P2	CCC (53)
g207 Anaplastic Astrocytoma	Pediatric Brain Tumor Consortium	P2	CCC (53)
Olutasidenib Anaplastic Astrocytoma	Rigel Pharmaceuticals	P2	CCC (53)
5-ala Anaplastic Astrocytoma	Universität Münster	P1	CC (47)
Adv/Hsv-Tk Anaplastic Astrocytoma	The Methodist Hospital Research Institute	P1/2	CC (45)
m032 Anaplastic Astrocytoma	University of Alabama at Birmingham	P1/2	CC (45)
Pembrolizumab Anaplastic Astrocytoma	University of Alabama at Birmingham	P1/2	CC (45)
Sargramostim Anaplastic Astrocytoma	Children's Oncology Group	P1	CC (44)
Ad5-yCD Anaplastic Astrocytoma	Henry Ford Health System	P1	CC (43)
ad5-ycd/muttksr39rep-adp adenovirus Anaplastic Astrocytoma	Henry Ford Health System	P1	CC (43)
c134 Anaplastic Astrocytoma	James Markert, MD	P1	CC (43)
Carboxylesterase-Expressing Allogeneic Neural Stem Cells Anaplastic Astrocytoma	City of Hope Medical Center	P1	CC (43)
Cyclophosphamide Anaplastic Astrocytoma	Dana-Farber Cancer Institute	P1	CC (43)
Nivolumab Anaplastic Astrocytoma	University of Florida	P1	CC (43)
Oncolytic Adenovirus Ad5-Dnx-2401 Anaplastic Astrocytoma	M.D. Anderson Cancer Center	P1	CC (43)
Rqnestin Anaplastic Astrocytoma	Dana-Farber Cancer Institute	P1	CC (43)
Vorinostat Anaplastic Astrocytoma	National Cancer Institute (NCI)	P1	CC (43)
Debio 0123 Anaplastic Astrocytoma	Debiopharm International SA	P1/2	CC (42)
Abexinostat Anaplastic Astrocytoma	University of Nebraska	P1	CC (41)
Onc 206 Anaplastic Astrocytoma	Jazz Pharmaceuticals	P1	CC (41)
Survaxm Anaplastic Astrocytoma	Children's Oncology Group	P1	CC (41)
Fimepinostat Anaplastic Astrocytoma	Sabine Mueller, MD, PhD	Early P1	C (39)
Lorlatinib Anaplastic Astrocytoma	Nationwide Children's Hospital	Early P1	C (38)